Science & Technology
SBIR Phase I: Massive, empirical, scalable generation of small molecule and protein interaction data to enable the discovery of medicines at scale with machine learning
National Science Foundation
Opportunity #: 2415314
Award Ceiling
$275K
Award Floor
$275K
Close Date
May 31, 2025
Total Funding
$275K
Expected Awards
1
Posted Date
Nov 22, 2024
Cost Sharing Required
No
Grants.gov ID
sbir-2415314
Description
SBIR Phase Phase I award: "SBIR Phase I: Massive, empirical, scalable generation of small molecule and protein interaction data to enable the discovery of medicines at scale with machine learning" awarded to Om Therapeutics Inc. in SAN DIEGO, California. Funded by National Science Foundation. Award amount: $275,000. The SBIR/STTR programs fund innovative research and development by small businesses, with Phase I for feasibility studies and Phase II for full R&D.
Eligible Applicants
Small businesses
Apply on Grants.gov
Always verify details and apply through the official Grants.gov portal. Information here may not reflect the latest changes.
View on Grants.govDisclaimer: This information is sourced from Grants.gov and may not reflect the most current details. Always verify eligibility requirements, deadlines, and application procedures on the official program website before applying.